Research from National and Kapodistrian University of Athens Provide New Insights into Gliomas [Emerging Role of the Slit/Roundabout (Robo) Signaling Pathway in Glioma Pathogenesis and Potential Therapeutic Options].

A report from the National and Kapodistrian University of Athens discusses the role of the Slit/Roundabout (Robo) signaling pathway in the development of gliomas, which are the most common primary Central Nervous System (CNS) tumors. Gliomas are characterized by their invasive properties and poor prognosis, and current therapies have limited effectiveness. The Slit/Robo signaling pathway has been identified as a potential target for glioma growth and immunotherapy, as it regulates tumor cells and their microenvironment. The report explores the implications of this pathway in glioma pathology and discusses potential therapeutic options, including immunotherapy and protein expression modifiers. [Extracted from the article]

Copyright of Immunotherapy Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)